Liangfang Zhang

University of California San Diego

Papers

11

Total Citations

2,875

H-Index

10

About

Liangfang Zhang stands at the forefront of biomedical nanorobotics and drug delivery, pioneering research that merges nanotechnology, biomimicry, and robotics to address complex medical challenges. His work focuses on designing micro- and nanoscale robots capable of autonomous movement and targeted therapeutic action within biological environments. His highly influential 2017 review on micro/nanorobots for biomedicine — now exceeding 1,500 citations — established a definitive framework for the field, cataloging advances in delivery, surgery, sensing, and detoxification. Zhang has been particularly innovative in developing biohybrid systems that transform natural biological components — including platelets, microalgae, and immune cells — into functional robotic platforms. His platelet-camouflaged nanorobots demonstrated remarkable capacity for neutralizing biological threats, while his enzyme-powered Janus platelet robots introduced a new paradigm for active, targeted drug delivery. More recently, Zhang's algae-based microrobots have shown promise in treating inflammatory bowel disease, combating lung metastasis, and even capturing SARS-CoV-2 in wastewater. Collectively accumulating thousands of citations, his research represents a transformative vision for next-generation therapeutics, where living and engineered systems collaborate seamlessly to navigate, sense, and heal from within the body.

Research Focus

Key Achievements

10
H-Index
11
Papers
2,875
Total Citations
261
Avg Citations/Paper
🏆 Most Cited Paper
Micro/nanorobots for biomedicine: Delivery, surgery, sensing, and detoxification
1,503 citations · 2017
📈 Most Prolific Year: 2017 (2 Papers)
🤝 Key Collaborators: 47
🏛 Institutions: University of California San Diego

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago